Anavex Life Sciences Corp (AVXL)

[RedShoulder]

It is possible for Anavex to make a similar presentation at the AAIC from an interim analysis of their OLE extension trial with at least 100 patients over a longer time frame of treatment,

That's a huge stretch, I don't think they would be allowed any kind of presentation this late, and Missling doing that by butting in would be out of character.

If he has anything new worthy of a PR (FDA or TGA) it will be the week after when the SAVA dust settles.